Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,213.49
+41.34
(+0.51%)
FTSE 250
20,164.54
+112.21
(+0.56%)
AIM
771.53
+3.42
(+0.45%)
GBP/EUR
1.1652
-0.0031
(-0.26%)
GBP/USD
1.2546
+0.0013
(+0.11%)
Bitcoin GBP
50,777.79
-395.38
(-0.77%)
BRANDS
Meet one of the UK’s largest unknown start-ups
Video editing platform Veed has grown to 10 million users
Corvus Pharmaceuticals, Inc. (CRVS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9200
+0.1900
(+10.98%)
At close: 04:00PM EDT
2.0500
+0.13
(+6.77%)
After hours:
07:57PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
16,526
16,526
24,468
29,115
31,830
Selling general and administrative
6,881
6,881
8,097
9,515
11,930
Total operating expenses
23,407
23,407
32,565
38,630
43,760
Operating income or loss
-23,407
-23,407
-32,565
-38,630
-43,760
Interest expense
-
-
-
15
-
Total other income/expenses net
-5,206
-5,206
-9,396
-4,596
37,225
Income before tax
-27,029
-27,029
-41,307
-43,241
-5,995
Income from continuing operations
-27,029
-27,029
-41,307
-43,241
-5,995
Net income
-27,029
-27,029
-41,307
-43,241
-5,995
Net income available to common shareholders
-27,029
-27,029
-41,307
-43,241
-5,995
Basic EPS
-0.64
-
-0.89
-1.03
-0.20
Diluted EPS
-0.64
-
-0.89
-1.03
-0.20
Basic average shares
47,401
-
46,554
41,854
29,479
Diluted average shares
47,401
-
46,554
41,854
29,479
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.